Chitotriosidase as a possible marker of clinically evidenced atherosclerosis in dyslipidemic children

Journal of Pediatric Endocrinology and Metabolism

Volumn 27, Issue 7-8, 2014, Pages 701-708

  Kologlu, Turan ^a   Ucar, Sema Kalkan ^a   Levent, Erturk ^a   Akcay, Yasemin Delen ^a   Coker, Mahmut ^a   Sozmen, Eser Yildirim ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Carotid intima media thickness (cIMT); Chitotriosidase; Familial hypercholesterolemia; Flow mediated dilation (FMD); Macrophage activation

Indexed keywords

C REACTIVE PROTEIN; CHITOTRIOSIDASE; GELATINASE B; INTERLEUKIN 18; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; LOW DENSITY LIPOPROTEIN; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; YKL 40 PROTEIN; ADIPOCYTOKINE; BETA N ACETYLHEXOSAMINIDASE; BIOLOGICAL MARKER; CHI3L1 PROTEIN, HUMAN; LECTIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA;

ADOLESCENT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENZYME ACTIVITY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HUMAN; INFLAMMATION; MACROPHAGE ACTIVATION; MALE; OXIDATION; PROTEIN BLOOD LEVEL; BLOOD; BLOOD FLOW VELOCITY; HYPERLIPOPROTEINEMIA TYPE II; PHYSIOLOGY; PRESCHOOL CHILD; VASCULAR ENDOTHELIUM; VASODILATATION;

ADIPOKINES; ADOLESCENT; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; C-REACTIVE PROTEIN; CAROTID INTIMA-MEDIA THICKNESS; CHEMOKINE CCL3; CHEMOKINE CCL4; CHILD; CHILD, PRESCHOOL; ENDOTHELIUM, VASCULAR; HEXOSAMINIDASES; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; INFLAMMATION; LECTINS; MACROPHAGE ACTIVATION; VASODILATION;

EID: 84907165079     PISSN: 0334018X     EISSN: 21910251     Source Type: Journal    
DOI: 10.1515/jpem-2013-0365     Document Type: Article

References (34)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115-26
2. Boisvert WA. Modulation of atherogenesis by chemokines. Trends Cardiovasc Med 2004;14:161-5
3. Boot RG, Renkema GH, Strijland A, van Zonneveld AJ, Aerts JM. Cloning of a cDNA encoding ChT, a human chitinase produced by macrophages. J Biol Chem 1995;270:26252-6
4. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 200 4;25:677-86
5. Karadag B, Kucur M, Isman FK, Hacibekiroglu M, Vural VA. Serum chitotriosidase activity in patients with coronary artery disease. Circ J 2008;72:71-5
6. Artieda M, Cenarro A, Ga ñán A, Jericó I, Gonzalvo C, et al. Serum ChT activity is increased in subjects with atherosclerosis disease. Arterioscler Thromb Vasc Biol 2003;23:1645-52
7. Zheng JL, Lua L, Hu J, Zhang RY, Zhang Q, et al. Increased serum YKL-40 and C-reactive protein levels are associated with angiographic lesion progression in patients with coronary artery disease. Atherosclerosi s 2010;210:590-5
8. Rathcke CN, Raymond I, Kistorp C, Hildebrandt P, Faber J, et al. Low grade inflammation as measured by levels of YKL-40: association with an increased overall and cardiovascular mortality rate in an elderly population. Int J Cardiol 2010;143:35-42
9. Kastrup J, Johansen JS, Kastrup J, Johansen JS, Winkel P, et al. CLARICOR Trial Group. High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease. Eur Heart J 2009;30:1066-72
10. Kucur M, Isman FK, Karadag B, Vural VA, Tavsanoglu S. Serum YKL-40 levels in patients with coronary artery disease. Coron Artery Dis 2007;18:391-6
11. Johansen JS, Pedersen AN, Schroll M, Jørgensen T, Pedersen BK, et al. High serum YKL-40 level in a cohort of octogenarians is associated with increased risk of all-cause mortality. Clin Exp Immunol 2008;151:260-6
12. Messal ME, Beaudeux JL, Drissi A, Giral P. Chat er R, et al. Elevated serum levels of proinflammatory cytokines and biomarkers of matrix remodeling in never-treated patients with familial hypercholesterolemia. Clin Chim Acta 2006;366:185-9
13. Hollak CE, van Weely S, van Oers MH, Aerts JM. Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Invest 1994;93:1288-92
14. Buege JA, Aust SD. M icrosomal lipid peroxidation methods enzymol. Clin Chem 1978;52:302-10
15. Grisham MB, Hernandez CA, Granger N. Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am J Physiol 1986;251:567-74
16. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, et al. Noninvasive detection of endothelial dysfunction in children and adults at risk of atheroscleros is. Lancet 1992;340:1111-6
17. Zannad F, Sass C, Visvikis S. Environmental and genetic determinants of intima-media thickness of the carotid artery. Clin Exp Pharmacol Physiol 2001;28:1007-10
18. Tonstad S, Joakimsen O, Stensland-Bugge E, Leren TP, Ose L, et al. Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and cont rol subjects. Arterioscler Thromb Vasc Biol 1996;16: 984-91
19. Charakida M, Tousoulis D, Skoumas I, Pitsavos C, Vasiliadou C, et al. Inflammatory and thrombotic processes are associated with vascular dysfunction in children with familial hypercholesterolemia. Atherosclerosis 2009b ;204:532-7
20. Loffredo L, Martino F, Carnevale R, Pignatelli P, Catasca E, et al. Obesity and hypercholesterolemia are associated with NOX2 generated oxidative stress and arterial dysfunction. J Pediatr 2012;161:1004-9
21. Martino F, Pignatelli P, Mart ino E, Morrone F, Carnevale R, et al. Early increase of oxidative stress and soluble CD40L in children with hypercholesterolemia. J Am Coll Cardiol 2007;49:1974-81
22. Rodenburg J, Vissers M N, Wiegman A, Miller ER, Ridker PM, et al. Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: effect of pravastatin. J Am Coll Cardiol 2006;47:1803-10
23. Morrow DA, Sabatine MS, Brennan ML, de Lemos JA, Murphy SA, et al. Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic event s in TACTICS-TIMI. Eur Heart J 2008;29:1096-102
24. Schindhelm RK, van der Zwan LP, Teerlink T, Scheffer PG. Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification? Clin Chem 2009;55:1462-70
25. Pignatelli P, Loffredo L, Martinoc F, Catascac E, Carnevale R, et al. Myeloperoxidase overexpression in children with hypercholesterolemia. Atherosclerosis 20 09;205:239-43
26. Charakida M, Deanfield JE. Myeloperoxidase expression in early life. On the causal pathways for atherosclerosis? Atherosclerosis 2009;205:37-8
27. J uonala M, Viikari JSA, Rö nnemaa T, Taittonen L, Marniemi J, et al. Childhood C-reactive protein in predicting CRP and carotid intima-media thickness in adulthood. The Cardiovascular Risk in Young Finns Study. Arterioscler Thro mb Vasc Biol 2006;26:1883-8
28. Khera A, de Lemos JA, Peshock RM, Lo HS, Stanek HG, et al. Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study. Circulation 2006;113:38-43
29. Zwaka TP, Hombach V, Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation 2001;103:1194-7
30. Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999;106:506-12
31. Narverud I, Uelandd T, Nenseterc MS, Retterstølc K, Telle-Hansena VH, et al. Children with familial hypercholesterolemia are characterized by an inflammatory imbalance between the tumor necrosis factor system and interleukin-10. Atherosclerosis 2011;214:163-8
32. Di Rosa M, Musumeci M, Scuto A, Musumeci S, Malaguarnera L. Effect of interferon-6, interleukin-10, lipopolysaccharide and tumor necrosis factor-A on ChT synthesis in human macrophages. Clin Chem Lab Med 2005;43:499-502
33. Kawada M, Hachiya Y, Arihiro A, Mizoguchi E. Role of mammalian chitinases in inflammatory conditions. Keio J Med 2007;56:21-7
34. Michelsena AE, Rathcke CN, Skjelland M, Holma S, Ranheima T, et al. Increased YKL-40 expression in patients with carotid atherosclerosis. Atherosclerosis 2010;211: 589-95